Yosef Yarden, Ph.D.

Weizmann Institute of Science, Rehovot, Israel 
Cell Biology, Oncology
"Yosef Yarden"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hoshino A, Kim HS, Bojmar L, et al. (2020) Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell
Maron R, Schechter B, Nataraj NB, et al. (2019) Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies. Biochemical and Biophysical Research Communications
Arandkar S, Furth N, Elisha Y, et al. (2018) Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features. Proceedings of the National Academy of Sciences of the United States of America
Roth L, Srivastava S, Lindzen M, et al. (2018) SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors. Science Signaling. 11
Enuka Y, Feldman ME, Chowdhury A, et al. (2017) Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone. Nucleic Acids Research
Tarcic O, Granit RZ, Pateras IS, et al. (2017) RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer. Cell Death and Differentiation
Bublil EM, Cohen T, Arnusch CJ, et al. (2016) Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain Derived Peptides Inhibits Tumorigenic Growth in Vitro and In Vivo. Biochemistry
Sas-Chen A, Aure MR, Leibovich L, et al. (2016) LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. Embo Molecular Medicine
Tóth G, Szöőr Á, Simon L, et al. (2016) The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity. Mabs. 0
Grossman M, Ben-Chetrit N, Zhuravlev A, et al. (2016) Tumor cell invasion can be blocked by modulators of collagen fibril alignment that control assembly of the extracellular matrix. Cancer Research
See more...